Ataxia-televangelist mutated (ATM)/ ATR serine/threonine kinase (ATR)-mediated RAD51 recombinase (RAD51) promotes osteogenic differentiation and inhibits osteoclastogenesis in osteoporosis

References

• Ensrud KE, Crandall CJ. Osteoporosis. Ann Intern Med. 2017 Aug 1;167(3):ITC17–ITC32.
   PubMed Web of Science ®Google Scholar
• Johnston CB, Dagar M. Osteoporosis in Older Adults. Med Clin North Am. 2020 Sep;104(5):873–884.
   PubMed Web of Science ®Google Scholar
• Eastell R, Szulc P. Use of bone turnover markers in postmenopausal osteoporosis. Lancet Diabetes Endocrinol. 2017 Nov;5(11):908–923.
   PubMed Web of Science ®Google Scholar
• Föger-Samwald U, Dovjak P, Azizi-Semrad U, et al. Osteoporosis: pathophysiology and therapeutic options. EXCLI J. 2020 Jul 20;19: 1017–1037.
   PubMed Web of Science ®Google Scholar
• Wang L, Hu YQ, Zhao ZJ, et al. Screening and validation of serum protein biomarkers for early postmenopausal osteoporosis diagnosis. Mol Med Rep. 2017 Dec;16(6):8427–8433.
   PubMed Web of Science ®Google Scholar
• Miller PD. Management of severe osteoporosis. Expert Opin Pharmacother. 2016;17(4):473–488.
   PubMed Web of Science ®Google Scholar
• Cotts KG, Cifu AS. Treatment of osteoporosis. JAMA. 2018 Mar 13;319(10):1040–1041.
   PubMed Web of Science ®Google Scholar
• Kim JM, Lin C, Stavre Z, et al. Osteoblast-osteoclast communication and bone homeostasis. Cells. 2020 Sep 10;9(9):2073.
   PubMed Web of Science ®Google Scholar
• Schröder K. NADPH oxidases in bone homeostasis and osteoporosis. Free Radic Biol Med. 2019 Feb 20;132: 67–72.
   PubMed Web of Science ®Google Scholar
• An J, Yang H, Zhang Q, et al. Natural products for treatment of osteoporosis: the effects and mechanisms on promoting osteoblast-mediated bone formation. Life Sci. 2016 Feb 15;147: 46–58.
   PubMed Web of Science ®Google Scholar
• Zhao X, Patil S, Xu F, et al. Role of biomolecules in osteoclasts and their therapeutic potential for osteoporosis. Biomolecules. 2021 May 17;11(5):747.
   PubMed Web of Science ®Google Scholar
• Bonilla B, Hengel SR, Grundy MK, et al. RAD51 gene family structure and function. Annu Rev Genet. 2020 Nov 23;54(1):25–46.
   PubMedGoogle Scholar
• Godin SK, Sullivan MR, Bernstein KA. Novel insights into RAD51 activity and regulation during homologous recombination and DNA replication. Biochem Cell Biol. 2016 Oct;94(5):407–418.
   PubMedGoogle Scholar
• Wassing IE, Esashi F. RAD51: beyond the break. Semin Cell Dev Biol. 2021May;113:38–46.
   PubMed Web of Science ®Google Scholar
• Blackford AN, Jackson SP. ATM, ATR, and DNA-PK: the trinity at the heart of the DNA damage response. Mol Cell. 2017 Jun 15;66(6):801–817.
   PubMed Web of Science ®Google Scholar
• Luo K, Li L, Li Y, et al. A phosphorylation-deubiquitination cascade regulates the BRCA2-RAD51 axis in homologous recombination. Genes Dev. 2016 Dec 1;30(23):2581–2595.
   PubMed Web of Science ®Google Scholar
• Humphryes N, Hochwagen A. A non-sister act: recombination template choice during meiosis. Exp Cell Res. 2014 Nov 15;329(1):53–60.
   PubMed Web of Science ®Google Scholar
• Prakash R, Zhang Y, Feng W, et al. Homologous recombination and human health: the roles of BRCA1, BRCA2, and associated proteins. Cold Spring Harb Perspect Biol. 2015 Apr 1;7(4):a016600.
   PubMed Web of Science ®Google Scholar
• Bogliolo M, Surrallés J. Fanconi anemia: a model disease for studies on human genetics and advanced therapeutics. Curr Opin Genet Dev. 2015Aug;33:32–40.
   PubMed Web of Science ®Google Scholar
• Mazon M, Julien J, Ung RV, et al. Deletion of the fanconi anemia C gene in mice leads to skeletal anomalies and defective bone mineralization and microarchitecture. J Bone Miner Res. 2018 Nov;33(11):2007–2020.
   PubMed Web of Science ®Google Scholar
• Cai N, Li C, Wang F. Silencing of LncRNA-ANCR promotes the osteogenesis of osteoblast cells in postmenopausal osteoporosis via targeting EZH2 and RUNX2. Yonsei Med J. 2019 Aug;60(8):751–759.
   PubMed Web of Science ®Google Scholar
• Wang Z, Wang D, Yang D, et al. The effect of icariin on bone metabolism and its potential clinical application. Osteoporos Int. 2018 Mar;29(3):535–544.
   PubMed Web of Science ®Google Scholar
• Li F, Wu H, Zou G, et al. Circular RNA_0062582 promotes osteogenic differentiation of human bone marrow mesenchymal stem cells via regulation of microRNA-145/CBFB axis. Bioengineered. 2021 Dec;12(1):1952–1963.
   PubMed Web of Science ®Google Scholar
• Li W, Zhang S, Liu J, et al. Vitamin K2 stimulates MC3T3-E1 osteoblast differentiation and mineralization through autophagy induction. Mol Med Rep. 2019 May;19(5):3676–3684.
   PubMed Web of Science ®Google Scholar
• Sun L, Lian JX, Meng S. MiR-125a-5p promotes osteoclastogenesis by targeting TNFRSF1B. Cell Mol Biol Lett. 2019 Mar 28;24(1):23.
   PubMed Web of Science ®Google Scholar
• Luo J, Yang Z, Ma Y, et al. LGR4 is a receptor for RANKL and negatively regulates osteoclast differentiation and bone resorption. Nat Med. 2016 May;22(5):539–546.
   PubMed Web of Science ®Google Scholar
• Laurini E, Marson D, Fermeglia A, et al. Role of Rad51 and DNA repair in cancer: a molecular perspective. Pharmacol Ther. 2020Apr;208:107492.
   PubMed Web of Science ®Google Scholar
• Sharma R, Martins N. Telomeres, DNA damage and ageing: potential leads from ayurvedic rasayana (Anti-Ageing) drugs. J Clin Med. 2020 Aug 6;9(8):2544.
   PubMed Web of Science ®Google Scholar
• Dai L, Schurgers LJ, Shiels PG, et al. Early vascular ageing in chronic kidney disease: impact of inflammation, vitamin K, senescence and genomic damage. Nephrol Dial Transplant. 2020 Mar 1;35(Suppl 2):ii31–ii37.
   PubMedGoogle Scholar
• Wang X, Li B. Genetic studies of bone diseases: evidence for involvement of DNA damage response proteins in bone remodeling. Int J Biomed Sci. 2007 Dec;3(4):217–228.
   PubMedGoogle Scholar
• Brown C. Osteoporosis: staying strong. Nature. 2017 Oct 4;550(7674):S15–S17.
   PubMed Web of Science ®Google Scholar
• Li X, Heyer WD. Homologous recombination in DNA repair and DNA damage tolerance. Cell Res. 2008 Jan;18(1):99–113.
   PubMed Web of Science ®Google Scholar
• Xu H, Xiong C, Chen Y, et al. Identification of Rad51 as a prognostic biomarker correlated with immune infiltration in hepatocellular carcinoma. Bioengineered. 2021 Dec;12(1):2664–2675.
   PubMed Web of Science ®Google Scholar
• Sarwar R, Sheikh AK, Mahjabeen I, et al. Upregulation of RAD51 expression is associated with progression of thyroid carcinoma. Exp Mol Pathol. 2017 Jun;102(3):446–454.
   PubMed Web of Science ®Google Scholar
• Ma M, Rodriguez A, Sugimoto K. Activation of ATR-related protein kinase upon DNA damage recognition. Curr Genet. 2020 Apr;66(2):327–333.
   PubMed Web of Science ®Google Scholar
• Corcoles-Saez I, Dong K, Cha RS. Versatility of the Mec1(ATM/ATR) signaling network in mediating resistance to replication, genotoxic, and proteotoxic stresses. Curr Genet. 2019 Jun;65(3):657–661.
   PubMed Web of Science ®Google Scholar
• Menolfi D, Zha S. ATM, ATR and DNA-PKcs kinases-the lessons from the mouse models: inhibition deletion. Cell Biosci. 2020 Jan 29;10(1):8.
   PubMed Web of Science ®Google Scholar
• Regal JA, Festerling TA, Buis JM, et al. Disease-associated MRE11 mutants impact ATM/ATR DNA damage signaling by distinct mechanisms. Hum Mol Genet. 2013 Dec 20;22(25):5146–5159.
   PubMed Web of Science ®Google Scholar
• Gao A, Guo M. Epigenetic based synthetic lethal strategies in human cancers. Biomark Res. 2020 Sep 15;8: 44.
   PubMed Web of Science ®Google Scholar
• Ahlskog JK, Larsen BD, Achanta K, et al. ATM/ATR-mediated phosphorylation of PALB2 promotes RAD51 function. EMBO Rep. 2016 May;17(5):671–681.
   PubMed Web of Science ®Google Scholar